AmplifyBio
West Jefferson, US · Founded 2021 · Delaware LLC · 4 known investors
Find your way into AmplifyBio
Sign up to see every warm intro you have to AmplifyBio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the AmplifyBio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Life sciences platform accelerating development of next-generation therapies
Founders & leadership
KJ
Kelly J. GanjeiExecutive
RA
Russell AustinNamed on SEC filing
Investors · 4
Viking Globallisted by Viking GlobalStamford
How we know: Viking Global's portfolio page · Not right? Tell us
Casdin CapitalreportedNew York
How we know: funding news · Not right? Tell us
Narya CapitalreportedColumbus
How we know: funding news · Not right? Tell us
Viking Global InvestorsreportedStamford
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$229.8M disclosed across 3 rounds · 2021–2023
▶$49.8MraisedNov 2023 · 4 investors · BiotechnologyRule 506(b)
▶$49.8MraisedNov 2023 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lewis Von ThaerDirector
- Shaun RodriguezDirector
- James Kelly GanjeiExecutive Officer
- Rohan NirodyDirector
- Matt VaughanDirector
- Offering amount
- $100M
- Amount sold
- $49.8M
- First sale
- Oct 2023
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 06b
▶$100MraisedJun 2022 · 8 investors · BiotechnologyRule 506(b)
▶$100MraisedJun 2022 · 8 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Lewis Von ThaerDirector
- Shaun RodriguezDirector
- Matt VaughanDirector
- Rohan NirodyDirector
- James Kelly GanjeiExecutive Officer
- Offering amount
- $100M
- Amount sold
- $100M
- First sale
- Apr 2022
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 06b
▶$80MraisedMay 2021 · 3 investors · BiotechnologyRule 506(b)
▶$80MraisedMay 2021 · 3 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kelly J. GanjeiExecutive Officer
- Russell AustinDirector, Promoter
- Offering amount
- $80M
- Amount sold
- $80M
- First sale
- Apr 2021
- Incorporated
- Limited Liability Company, Delaware, 2021
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does AmplifyBio do?
- Life sciences platform accelerating development of next-generation therapies
- Who are AmplifyBio's investors?
- AmplifyBio's investors include Viking Global, Casdin Capital, Narya Capital, Viking Global Investors.
- How much funding has AmplifyBio raised?
- AmplifyBio has disclosed $229.8M raised across 3 rounds.
- Where is AmplifyBio headquartered?
- AmplifyBio is headquartered in West Jefferson, US.
